贸易债权人 更改
Agenus USD 71.08M 11.9M 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Celldex Therapeutics USD 10.36M 9.18M 2026-03
Eisai JPY 75.89B 9.6B 2026-03
Merck USD 3.86B 541M 2026-03
Northwest Biotherapeutics 36.72M 9.49M 2025-09
Pfizer USD 4.51B 734M 2026-03
Plus Therapeutics 5.92M 5.7M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12